SPOTLIGHT -
Washington-A Florida urologist is slated to become the highest-ranked health official in Iraq-albeit temporarily.
Active surveillance does not increase malpractice risk across cancers
“This data should bolster physicians’ confidence in recommending active surveillance for their patients when it is an appropriate option," says Timothy J. Daskivich, MD.
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Urine-based assay demonstrates predictive efficacy in MIBC
The AssureMDx test demonstrated an area under the curve of 0.80 in detecting urinary tract recurrences in MIBC.
Dr. Murphy on increasing diversity in cancer clinical trials
In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
Multicomponent intervention linked with improved QOL in patients with OAB
In the intervention group, the HRQOL score changed by 23.9 points between baseline and week 13, from 18.4 to 29.5.
Galen Prostate demonstrates diagnostic value in prostate cancer
Overall, participating pathologists felt that there is potential to increase diagnostic efficiency by using Galen Prostate in a clinical setting.